Clinical trial
Lupron Sex Offender Therapy
NCT00220350 · Schober, Justine, M.D., Other · Unknown status
Key facts
| NCT number | NCT00220350 |
|---|---|
| Title | Lupron Sex Offender Therapy |
| Official title | Leuprolide Acetate Suppresses Pedophilic Urges and Arousability |
| Lead sponsor | Schober, Justine, M.D., Other |
| Collaborators | TAP Pharmaceutical Products Inc. Industry |
| Status | Unknown status |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Pedophilia |
| Intervention type | Drug |
| Interventions | leuprolide acetate |
| Enrollment | 10 |
| Start date | Oct 1, 2001 |
| Completion | Aug 1, 2005 |
| First posted | Sep 22, 2005 |
| Last update posted | Sep 22, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: